DE602005017815D1 - Behandlung von entzündlicher darmerkrankung - Google Patents
Behandlung von entzündlicher darmerkrankungInfo
- Publication number
- DE602005017815D1 DE602005017815D1 DE602005017815T DE602005017815T DE602005017815D1 DE 602005017815 D1 DE602005017815 D1 DE 602005017815D1 DE 602005017815 T DE602005017815 T DE 602005017815T DE 602005017815 T DE602005017815 T DE 602005017815T DE 602005017815 D1 DE602005017815 D1 DE 602005017815D1
- Authority
- DE
- Germany
- Prior art keywords
- endurance
- inflammatory
- treatment
- animal
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/999,451 US7326716B2 (en) | 2003-06-06 | 2004-11-29 | Treatment of inflammatory bowel disease |
PCT/US2005/042467 WO2006058080A1 (en) | 2004-11-29 | 2005-11-22 | Treatment of inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005017815D1 true DE602005017815D1 (de) | 2009-12-31 |
Family
ID=35903405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005017815T Active DE602005017815D1 (de) | 2004-11-29 | 2005-11-22 | Behandlung von entzündlicher darmerkrankung |
Country Status (10)
Country | Link |
---|---|
US (1) | US7326716B2 (de) |
EP (1) | EP1817033B1 (de) |
AT (1) | ATE448785T1 (de) |
AU (1) | AU2005309622A1 (de) |
BR (1) | BRPI0518690A2 (de) |
CA (1) | CA2589438C (de) |
DE (1) | DE602005017815D1 (de) |
DK (1) | DK1817033T3 (de) |
ES (1) | ES2334374T3 (de) |
WO (1) | WO2006058080A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700627B2 (en) * | 2006-07-26 | 2010-04-20 | Allergan, Inc. | Therapeutic substituted lactams |
CA2728161C (en) * | 2008-06-23 | 2017-06-06 | Nippon Shinyaku Co., Ltd. | Therapeutic agent for inflammatory bowel disease |
EP2198879A1 (de) | 2008-12-11 | 2010-06-23 | Institut Curie | CD74-modulierender Wirkstoff zur Regulierung der Dendritenzellmigration und Verfahren zur Untersuchung der Bewegungsfähigkeit einer Zelle |
EP2199273B1 (de) | 2008-12-18 | 2018-02-21 | Agfa Nv | Polymerisierbare Fotoinitiatoren und strahlungshärtbare Zusammensetzungen |
WO2010133381A1 (en) | 2009-05-18 | 2010-11-25 | Agfa Graphics Nv | Polymerizable polymeric photoinitiators and radiation curable compositions |
US20120190637A1 (en) | 2009-10-14 | 2012-07-26 | Gemmus Pharma, Inc. | Combination therapy treatment for viral infections |
ES2565984T3 (es) | 2010-10-20 | 2016-04-08 | Agfa Graphics N.V. | Fotoiniciadores polimerizables para composiciones curables por LED |
US20140142042A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
MX2016001714A (es) | 2013-08-09 | 2016-10-03 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
EP2868650B1 (de) | 2013-10-30 | 2018-08-08 | Agfa Nv | Synthese von Acetalverbindungen unter Verwendung von zwitterionischen Katalysatoren |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028624A (en) * | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
US5034413A (en) * | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
CA2021316C (en) * | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
SE520947C2 (sv) * | 2002-01-18 | 2003-09-16 | Aneo Ab | Ventilarrangemang för blandning av två medier |
WO2004029581A2 (en) * | 2002-09-26 | 2004-04-08 | The Children's Hospital Of Philadelphia | Method of determining surface binding capacity |
US7053085B2 (en) | 2003-03-26 | 2006-05-30 | Merck & Co. Inc. | EP4 receptor agonist, compositions and methods thereof |
JP2006515015A (ja) * | 2003-01-10 | 2006-05-18 | エフ.ホフマン−ラ ロシュ アーゲー | プロスタグランジンアゴニストとしての2−ピペリドン誘導体 |
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
US6977260B2 (en) * | 2004-01-22 | 2005-12-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
US6747037B1 (en) * | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
DE10341727A1 (de) * | 2003-09-10 | 2005-04-28 | Starck H C Gmbh | Reinigung von Ammoniummetallat-Lösungen |
EP1761495B1 (de) | 2004-06-04 | 2012-03-21 | Allergan, Inc. | Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel |
-
2004
- 2004-11-29 US US10/999,451 patent/US7326716B2/en active Active
-
2005
- 2005-11-22 AT AT05846549T patent/ATE448785T1/de not_active IP Right Cessation
- 2005-11-22 EP EP05846549A patent/EP1817033B1/de not_active Not-in-force
- 2005-11-22 BR BRPI0518690-0A patent/BRPI0518690A2/pt not_active IP Right Cessation
- 2005-11-22 DK DK05846549.3T patent/DK1817033T3/da active
- 2005-11-22 ES ES05846549T patent/ES2334374T3/es active Active
- 2005-11-22 CA CA2589438A patent/CA2589438C/en not_active Expired - Fee Related
- 2005-11-22 DE DE602005017815T patent/DE602005017815D1/de active Active
- 2005-11-22 WO PCT/US2005/042467 patent/WO2006058080A1/en active Application Filing
- 2005-11-22 AU AU2005309622A patent/AU2005309622A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK1817033T3 (da) | 2010-03-08 |
WO2006058080A1 (en) | 2006-06-01 |
CA2589438C (en) | 2014-07-22 |
ATE448785T1 (de) | 2009-12-15 |
US7326716B2 (en) | 2008-02-05 |
US20050171062A1 (en) | 2005-08-04 |
EP1817033A1 (de) | 2007-08-15 |
BRPI0518690A2 (pt) | 2008-12-02 |
CA2589438A1 (en) | 2006-06-01 |
EP1817033B1 (de) | 2009-11-18 |
AU2005309622A1 (en) | 2006-06-01 |
ES2334374T3 (es) | 2010-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005017815D1 (de) | Behandlung von entzündlicher darmerkrankung | |
EA200601239A1 (ru) | Замещённые хинолиновые соединения | |
NO20084502L (no) | Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
EA200501771A1 (ru) | Лиганды каннабиноидных рецепторов и их применения | |
MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
ATE445415T1 (de) | Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung | |
ATE478864T1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
EA200601841A1 (ru) | Композиции, содержащие ингибитор jnk и циклоспорин | |
MA31086B1 (fr) | Formulations de doses unitaires et procedes de traitement d'une thrombose avec un inhibiteur oral du facteur xa. | |
CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
ECSP066684A (es) | Nitrooxiderivados de prostaglandinas | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
EA200601895A1 (ru) | 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов | |
ATE446102T1 (de) | Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii | |
DE60219614D1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
EA200601607A1 (ru) | Сульфонамидные соединения для лечения нейродегенеративных расстройств | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
ATE491453T1 (de) | Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges | |
DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
ATE538796T1 (de) | Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |